Breaking News, Collaborations & Alliances

Mikart Partners with Fluid Pharma to Advance the Application of MicroCoat Technology

Will manufacture clinical trial materials using proprietary MicroCoat technology to advance new therapies.

Author Image

By: Charlie Sternberg

Associate Editor

Mikart LLC, a comprehensive contract development and manufacturing organization, has entered into a collaboration agreement with Fluid Pharma Ltd, a technology licensing company, to advance the application of Fluid Pharma’s  proprietary MicroCoat  technology in  new therapies for pediatric, geriatric, and oral liquid modified release applications, in North America.   Gus LaBella, director of Formulation Development at Mikart, commented, “MicroCoat technology will allow us to layer and co...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters